Literature DB >> 26141491

The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Rik Ossenkoppele1, Yolande A L Pijnenburg2, David C Perry3, Brendan I Cohn-Sheehy3, Nienke M E Scheltens2, Jacob W Vogel4, Joel H Kramer3, Annelies E van der Vlies2, Renaud La Joie4, Howard J Rosen3, Wiesje M van der Flier5, Lea T Grinberg6, Annemieke J Rozemuller2, Eric J Huang7, Bart N M van Berckel8, Bruce L Miller3, Frederik Barkhof8, William J Jagust4, Philip Scheltens2, William W Seeley6, Gil D Rabinovici9.   

Abstract

A 'frontal variant of Alzheimer's disease' has been described in patients with predominant behavioural or dysexecutive deficits caused by Alzheimer's disease pathology. The description of this rare Alzheimer's disease phenotype has been limited to case reports and small series, and many clinical, neuroimaging and neuropathological characteristics are not well understood. In this retrospective study, we included 55 patients with Alzheimer's disease with a behavioural-predominant presentation (behavioural Alzheimer's disease) and a neuropathological diagnosis of high-likelihood Alzheimer's disease (n = 17) and/or biomarker evidence of Alzheimer's disease pathology (n = 44). In addition, we included 29 patients with autopsy/biomarker-defined Alzheimer's disease with a dysexecutive-predominant syndrome (dysexecutive Alzheimer's disease). We performed structured chart reviews to ascertain clinical features. First symptoms were more often cognitive (behavioural Alzheimer's disease: 53%; dysexecutive Alzheimer's disease: 83%) than behavioural (behavioural Alzheimer's disease: 25%; dysexecutive Alzheimer's disease: 3%). Apathy was the most common behavioural feature, while hyperorality and perseverative/compulsive behaviours were less prevalent. Fifty-two per cent of patients with behavioural Alzheimer's disease met diagnostic criteria for possible behavioural-variant frontotemporal dementia. Overlap between behavioural and dysexecutive Alzheimer's disease was modest (9/75 patients). Sixty per cent of patients with behavioural Alzheimer's disease and 40% of those with the dysexecutive syndrome carried at least one APOE ε4 allele. We also compared neuropsychological test performance and brain atrophy (applying voxel-based morphometry) with matched autopsy/biomarker-defined typical (amnestic-predominant) Alzheimer's disease (typical Alzheimer's disease, n = 58), autopsy-confirmed/Alzheimer's disease biomarker-negative behavioural variant frontotemporal dementia (n = 59), and controls (n = 61). Patients with behavioural Alzheimer's disease showed worse memory scores than behavioural variant frontotemporal dementia and did not differ from typical Alzheimer's disease, while executive function composite scores were lower compared to behavioural variant frontotemporal dementia and typical Alzheimer's disease. Voxel-wise contrasts between behavioural and dysexecutive Alzheimer's disease patients and controls revealed marked atrophy in bilateral temporoparietal regions and only limited atrophy in the frontal cortex. In direct comparison with behavioural and those with dysexecutive Alzheimer's disease, patients with behavioural variant frontotemporal dementia showed more frontal atrophy and less posterior involvement, whereas patients with typical Alzheimer's disease were slightly more affected posteriorly and showed less frontal atrophy (P < 0.001 uncorrected). Among 24 autopsied behavioural Alzheimer's disease/dysexecutive Alzheimer's disease patients, only two had primary co-morbid FTD-spectrum pathology (progressive supranuclear palsy). In conclusion, behavioural Alzheimer's disease presentations are characterized by a milder and more restricted behavioural profile than in behavioural variant frontotemporal dementia, co-occurrence of memory dysfunction and high APOE ε4 prevalence. Dysexecutive Alzheimer's disease presented as a primarily cognitive phenotype with minimal behavioural abnormalities and intermediate APOE ε4 prevalence. Both behavioural Alzheimer's disease and dysexecutive Alzheimer's disease presentations are distinguished by temporoparietal-predominant atrophy. Based on the relative sparing of frontal grey matter, we propose to redefine these clinical syndromes as 'the behavioural/dysexecutive variant of Alzheimer's disease' rather than frontal variant Alzheimer's disease. Further work is needed to determine whether behavioural and dysexecutive-predominant presentations of Alzheimer's disease represent distinct phenotypes or a single continuum.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; executive function; frontal, behaviour; frontotemporal dementia

Mesh:

Substances:

Year:  2015        PMID: 26141491      PMCID: PMC4623840          DOI: 10.1093/brain/awv191

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  95 in total

Review 1.  The epidemiology of traumatic brain injury.

Authors:  John D Corrigan; Anbesaw W Selassie; Jean A Langlois Orman
Journal:  J Head Trauma Rehabil       Date:  2010 Mar-Apr       Impact factor: 2.710

2.  Frontal variant of Alzheimer's disease: clinico-CSF-pathological correlation.

Authors:  Mario Habek; Sanja Hajnsek; Kamelija Zarković; Darko Chudy; Zdenko Mubrin
Journal:  Can J Neurol Sci       Date:  2010-01       Impact factor: 2.104

3.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Authors:  Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

5.  Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.

Authors:  Bradford C Dickerson; David A Wolk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-20       Impact factor: 10.154

6.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

7.  Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment.

Authors:  Judy Pa; Adam Boxer; Linda L Chao; Adam Gazzaley; Katie Freeman; Joel Kramer; Bruce L Miller; Michael W Weiner; John Neuhaus; Julene K Johnson
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  Differentiating the frontal variant of Alzheimer's disease.

Authors:  Michael Woodward; Claudia Jacova; Sandra E Black; Andrew Kertesz; Ian R Mackenzie; Howard Feldman
Journal:  Int J Geriatr Psychiatry       Date:  2010-07       Impact factor: 3.485

9.  Alzheimer's disease (AD) and executive dysfunction. A case-control study on the significance of frontal white matter changes detected by diffusion tensor imaging (DTI).

Authors:  Martin Sjöbeck; Christina Elfgren; Elna-Marie Larsson; Sara Brockstedt; Jimmy Lätt; Elisabet Englund; Ulla Passant
Journal:  Arch Gerontol Geriatr       Date:  2009-05-05       Impact factor: 3.250

10.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2009-11-19       Impact factor: 17.088

View more
  134 in total

1.  A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.

Authors:  Anna C van Loenhoud; Alle Meije Wink; Colin Groot; Sander C J Verfaillie; Jos Twisk; Frederik Barkhof; Bart van Berckel; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

3.  Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.

Authors:  Gaël Chételat; Rik Ossenkoppele; Victor L Villemagne; Audrey Perrotin; Brigitte Landeau; Florence Mézenge; William J Jagust; Vincent Dore; Bruce L Miller; Stéphanie Egret; William W Seeley; Wiesje M van der Flier; Renaud La Joie; David Ames; Bart N M van Berckel; Philip Scheltens; Frederik Barkhof; Christopher C Rowe; Colin L Masters; Vincent de La Sayette; Femke Bouwman; Gil D Rabinovici
Journal:  Brain       Date:  2016-06-29       Impact factor: 13.501

4.  Skin Conduction Levels Differentiate Frontotemporal Dementia From Alzheimer's Disease.

Authors:  Mario F Mendez; Sylvia S Fong; Mark M Ashla; Elvira E Jimenez; Andrew R Carr
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-04-06       Impact factor: 2.198

5.  Approach to atypical Alzheimer's disease and case studies of the major subtypes.

Authors:  Bradford C Dickerson; Scott M McGinnis; Chenjie Xia; Bruce H Price; Alireza Atri; Melissa E Murray; Mario F Mendez; David A Wolk
Journal:  CNS Spectr       Date:  2017-02-15       Impact factor: 3.790

6.  Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.

Authors:  Nienke M E Scheltens; Betty M Tijms; Teddy Koene; Frederik Barkhof; Charlotte E Teunissen; Steffen Wolfsgruber; Michael Wagner; Johannes Kornhuber; Oliver Peters; Brendan I Cohn-Sheehy; Gil D Rabinovici; Bruce L Miller; Joel H Kramer; Philip Scheltens; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2017-04-17       Impact factor: 21.566

7.  Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.

Authors:  Alexandre Bejanin; Melissa E Murray; Peter Martin; Hugo Botha; Nirubol Tosakulwong; Christopher G Schwarz; Matthew L Senjem; Gael Chételat; Kejal Kantarci; Clifford R Jack; Bradley F Boeve; David S Knopman; Ronald C Petersen; Caterina Giannini; Joseph E Parisi; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

Review 8.  Neuroimaging Abnormalities in Neurological Patients with Criminal Behavior.

Authors:  R Ryan Darby
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-14       Impact factor: 5.081

Review 9.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.